Blake J. Bleier

Statistics

Publications

Citations

270

H-Index

Active since

2012

Affiliations

Gilead Sciences (United States)(Current)

Carnegie Mellon University

University of North Carolina at Chapel Hill

University of Washington

Blake J. Bleier is an author at Gilead Sciences (United States) specializing in antiviral pharmacotherapy, antiviral therapeutics, and antiviral pharmacology.

ORCID

Publications per year

2012–2023

Publications

Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice

Alexandra Schäfer, David R. Martinez, John J. Won et al. · Science Translational Medicine · 2022 · 83 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Discovery of GS-5245 (Obeldesivir), an Oral Prodrug of Nucleoside GS-441524 That Exhibits Antiviral Efficacy in SARS-CoV-2-Infected African Green Monkeys

Richard L. Mackman, Rao Kalla, Darius Babusis et al. · Journal of Medicinal Chemistry · 2023 · 63 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Near field capillary repulsion

Yao Lu, Lorenzo Botto, Marcello Cavallaro et al. · Soft Matter · 2012 · 53 citations

Engineering, Physics, Colloid Science +15

Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in mice

Alexandra Schäfer, David R. Martinez, John J. Won et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 24 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Microfluidic Droplet-Based Tool To Determine Phase Behavior of a Fluid System with High Composition Resolution

Blake J. Bleier, Shelley L. Anna, Lynn M. Walker · The Journal of Physical Chemistry B · 2018 · 15 citations

Engineering, Chemical Engineering, Materials Engineering +17

1–5 of 8